# US 2016/0243158 A1 · Method, composition and package for bowel cleansing

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0243158 A1
- Document ID: US20160243158A1
- Status: Published application
- Kind: A1
- Application number: 14/959,168
- Filed: 2015-12-04
- Published: 2016-08-25
- Earliest claimed: 2011-01-28
- Assignees: Braintree Laboratories, Inc.
- Applicants: Braintree Laboratories, Inc.
- Inventors: William A. Shaver
- Web page: https://patentgrep.com/patent/US20160243158A1

## CPC

- A61K 31/194: having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
- A61K 9/0007: {Effervescent (A61K9/0065 takes precedence)}
- A61K 9/009: {Sachets, pouches characterised by the material or function of the envelope (with gastric retention A61K9/0065; sachets which are not administered but function merely as a container are classified according to the content, e.g. sachets comprising powder for reconstitution of a drink A61K9/0095)}
- A61K 9/0095: {Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches (A61K9/0007 takes precedence; eatable gels or foams A61K9/0056; oral mucosa adhesive forms A61K9/006)}
- A61K 9/1623: {Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules}
- A61K 9/1641: {obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers}
- A61K 33/00: Medicinal preparations containing inorganic active ingredients
- A61K 33/06: Aluminium, calcium or magnesium; Compounds thereof {, e.g. clay}
- A61K 33/14: Alkali metal chlorides; Alkaline earth metal chlorides
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61K 47/02: Inorganic compounds
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/12: Carboxylic acids; Salts or anhydrides thereof
- A61K 47/26: Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 1/10: Laxatives
- A61P 3/12: for electrolyte homeostasis
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides a highly palatable colon cleansing formulation that utilizes a low chloride electrolyte-replenishing base solution. When formulated with polyethylene glycol and a selected sugar alcohol, the formulation offers the advantages of superior palatability without undesirable concomitant side effects or a decrease in cleansing efficacy.

## Claims

### Claim 1

A dry composition comprising a low chloride component, wherein the dry composition upon reconstitution in an aqueous diluent produces an electrolyte replenishing colon cleansing solution that contains between 1.5 and 20 mEq of chloride ions per liter of aqueous diluent.

### Claim 2 (depends on 1)

The dry composition of claim 1, further comprising
(a) polyethylene glycol; and/or
(b) a sugar alcohol.

### Claim 3

(canceled)

### Claim 4

A dry composition comprising polyethylene glycol and a sugar alcohol, wherein the dry composition upon reconstitution in an aqueous diluent produces an electrolyte replenishing colon cleansing solution in which the polyethylene glycol and the sugar alcohol are present in amounts sufficient to exhibit dual osmotic activity.

### Claim 5 (depends on 4)

The dry composition of claim 4, further comprising a low chloride component, such that the electrolyte replenishing colon cleansing solution contains between 1.5 and 20 mEq of chloride ions per liter of diluent.

### Claim 6 (depends on 1)

The dry composition of claim 1, wherein the colon cleansing solution contains less than 17 mEq of chloride ions per liter of aqueous diluent.

### Claim 7 (depends on 2)

The dry composition of claim 2, wherein the polyethylene glycol
(a) has a molecular weight between about 2000 and 8000 Daltons;
(b) is PEG-3350; and/or
(c) is present between about 50-140.0 grams per liter of aqueous diluent.

### Claim 8

(canceled)

### Claim 9

(canceled)

### Claim 10 (depends on 2)

The dry composition of claim 2, wherein the sugar alcohol
(a) is selected from the group consisting of xylitol, erythritol, ribitol, arabitol, and mixtures thereof; and/or
(b) is xylitol.

### Claim 11

(canceled)

### Claim 12 (depends on 10)

The dry composition of claim 10, wherein the dry composition comprises between about 4.0-50 g of xylitol per liter of aqueous diluent.

### Claim 13 (depends on 4)

The dry composition of claim 4, wherein the combination of polyethylene glycol and the sugar alcohol comprises at least about 90% by weight of said composition; and/or wherein the ratio of grams of polyethylene glycol to sugar alcohol is between about 2:1-60:1, 1.2:1-3.75:1 or 25:1-75:1.

### Claim 14

(canceled)

### Claim 15 (depends on 1)

The dry composition of claim 1, comprising sodium chloride.

### Claim 16 (depends on 15)

The dry composition of claim 15, wherein the dry composition comprises between 0.1-1.0 grams of sodium chloride per liter of aqueous diluent.

### Claim 17 (depends on 1)

The dry composition of claim 1, further comprising one or more non-chloride containing salts selected from the group consisting of potassium bicarbonate, sodium bicarbonate and citric acid.

### Claim 18 (depends on 17)

The dry composition of claim 17, wherein the citric acid is anhydrous citric acid.

### Claim 19 (depends on 17)

The dry composition of claim 17, wherein the dry composition comprises
(a) between about 1.0-4.0 grams of citric acid per liter of aqueous diluent;
(b) between about 0.15-1.5 grams of potassium bicarbonate per liter of aqueous diluent;
(c) between about 1.0-3.5 grams of sodium bicarbonate per liter of aqueous diluent; and/or
(d) sodium bicarbonate and citric acid in amounts effective to produce tri-sodium citrate.

### Claim at position 20

20-22. (canceled)

### Claim 23 (depends on 1)

The dry composition of claim 1, wherein the composition does not contain a purgative amount of sulfate or phosphate.

### Claim 24

An electrolyte replenishing colon cleansing solution comprising
between 1.5 and 20 mEq of chloride ions per liter of aqueous diluent; and polyethylene glycol and a sugar alcohol in amounts sufficient to exhibit dual osmotic activity.

### Claim 25 (depends on 24)

The colon cleansing solution of claim 24, wherein the colon cleansing solution
(a) has a perceived saltiness equivalent between about 0.1% to 0.3%; and/or
(b) has an osmolality between about 275 mOsm/kg and 500 mOsm/kg, optionally, wherein the osmolality is calculated osmolality.

### Claim 26

(canceled)

### Claim 27

(canceled)

### Claim 28 (depends on 24)

The colon cleansing solution of claim 24, wherein said solution
(a) comprises between about 10-60 mEq of Na+ ions;
(b) comprises between about 1.5-15 mEq of K+ ions;
(c) is substantially free of sulfate ions;
(d) is substantially free of phosphate ions; and/or
(e) is substantially free of magnesium ions.

### Claim at position 27

29-32. (canceled)

### Claim 33 (depends on 24)

A method for cleansing a patient's colon in preparation for colonoscopy or a medical, surgical, or radiological procedure, comprising administering to the patient an effective amount of the colon cleansing solution of claim 24, thereby cleansing the patient's colon.

### Claim 34 (depends on 33)

The method of claim 33, wherein the solution is administered as a split dose regimen.

### Claim 35 (depends on 34)

The method of claim 34, wherein a first dose of solution is administered in the evening prior to the colonoscopy or procedure and wherein a second dose of solution is administered either in the evening before or the morning of the colonoscopy or procedure.

### Claim 36 (depends on 35)

The method of claim 35, wherein the first dose comprises a one liter dose of solution; and/or wherein the second dose comprises a one liter dose of solution.

### Claim 37

(canceled)

### Claim 38 (depends on 34)

The method of claim 34, wherein the patient experiences breath methane levels at less than 7, 6, 5, 4, 3 or 2 ppm, as measured by a Quintron Breathalyzer, following administration of the solution.

### Claim 39 (depends on 1)

A method for preparing a colon cleansing solution, comprising reconstituting the dry composition of claim 1 in an aqueous diluent.

### Claim 40 (depends on 39)

The method of claim 39, wherein citric acid is added separately to the solution to elicit effervescence.

### Claim 41 (depends on 1)

A kit comprising the dry composition of claim 1.

### Claim 42 (depends on 41)

The kit of claim 41:
(a) wherein the kit contains one or more sachets;
(b) wherein the bicarbonate salts are separately compartmentalized from the citric acid;
(c) wherein the citric acid is present in tablet form; and/or
(d) wherein the kit further comprises a container sufficient to hold a volume of at least about 1 liter of an aqueous solution.

### Claim at position 38

43-45. (canceled)
